Biostatistics, Bioinformatics and Epidemiology Program (BBE) supplies the statistical and mathematical modeling expertise needed within Fred Hutch’s Vaccine and Infectious Disease Division to accomplish our ambitious objective of eliminating disease and death attributable to infection. We are also accelerating research to confront the growing burden of cancer worldwide.
The BBE's nearly 34 faculty members model epidemics, research statistical methods to design complex global clinical trials, and analyze biological assays to better understand infectious disease processes and immune responses.
A hallmark of BBE is the simultaneous pursuit of excellence in both methodological and applied science. Researchers frequently develop novel mathematical approaches to better answer scientific questions that continually emerge from ongoing studies within the division.
BBE faculty members are experts in five key quantitative disciplines: biostatistics, bioinformatics, computational biology, infectious disease epidemiology and mathematical modeling.
Fred Hutch directs major worldwide, multicenter studies to model the spread of infectious diseases and to combat the global HIV/AIDS epidemic. Our biostatisticians play leadership roles in these initiatives.
Fred Hutch serves as the statistical and data management center for several international collaborative studies aiming to develop safe, effective vaccines, preventions, and therapies to combat HIV/AIDS. BBE faculty members contribute critical expertise to these networks. This includes designing experimental protocols, innovating statistical methods for data analysis and analyzing and interpreting study data.
A Fred Hutch faculty member since 2007, Dr. Peter Gilbert is program head of the Biostatistics, Bioinformatics and Epidemiology program. He guides the overall vision and research direction of BBE while collaborating with and mentoring junior faculty, young investigators, and graduate students.
As lead investigator for the statistical center for HVTN, a significant global HIV/AIDS vaccine initiative, Dr. Gilbert’s research focuses on the statistical design and analysis of large-scale international vaccine efficacy trials, with an emphasis on assessing immune correlates of vaccine-induced protection.
One of the world’s foremost authorities on the HIV epidemic, Dr. Gilbert’s leadership was instrumental in developing a novel process for identifying correlates of immunity in the landmark RV144 “Thai Trial.”
Dr. Gilbert is also a full member in the Public Health Sciences Division of Fred Hutch and a Research Professor in the Department of Biostatistics at the University of Washington.